Oral News and Research

RSS

IV iron dextran more cost-effective than oral iron for women with heavy menstrual bleeding and IDA

A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new research published in Blood Advances.

8 Jan 2026

Arginine can modify plaque formation on teeth and protect against dental caries

New human clinical trial proves arginine, an amino acid, can modify plaque formation on teeth, thereby protecting against dental caries.

8 Jan 2026

Sugarcane protein mouthwash helps protect oral health during head and neck cancer treatment

An artificial saliva in the form of a mouthwash, produced with the CANECPI-5 protein extracted from sugarcane and modified in a laboratory, can aid in treating teeth in patients with head and neck cancer. In these cases, radiotherapy very close to the mouth can destroy salivary glands and compromise saliva production, which is essential for controlling bacteria and disease.

7 Jan 2026

Breast milk bacteria help shape infant gut microbiome development

Most conversations about breast milk tend to focus on topics like nutrients, antibodies and bonding time rather than bacteria.

7 Jan 2026

Single-dose oral cholera vaccine shows promising results in early clinical trial

Clinical trial shows promising results for PanChol, a single-dose oral vaccine aimed at the up to 4 million annual cholera cases worldwide.

7 Jan 2026

BATF2: A novel tumor suppressor silenced by glutamine in head and neck cancer

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to researchers from The University of Texas MD Anderson Cancer Center.

7 Jan 2026

Cornell-developed nanoparticles improve cancer immunotherapy effectiveness

A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to rally the immune system against melanoma and dramatically improve the effectiveness of cancer immunotherapy, according to a new study led by Weill Cornell Medicine and Cornell Engineering researchers.

7 Jan 2026

Enveda’s third asset to the clinic with US FDA IND clearance: What it means for Inflammatory Bowel Disease

Enveda, a multi-asset clinical-stage biotech company pioneering the discovery and development of a new generation of small-molecule drugs derived from life’s chemistry, has announced that the US Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for ENV-6946.

From Hanson Wade Group - 4th Precision Medicine in Inflammatory Bowel Disease Summit 6 Jan 2026

New breakthrough could modernize treatment for glioblastoma

Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could modernize treatment for glioblastoma, a fast-growing and deadly form of brain cancer.

6 Jan 2026

Streptococcus anginosus metabolites fuel gastric cancer

A recent study published in the medical journal Gut has revealed a novel cancer-promoting mechanism of Streptococcus anginosus (Sa).

6 Jan 2026

New evidence reveals Streptococcus anginosus promotes gastric cancer development

This study identifies a cancer-promoting mechanism of Streptococcus anginosus, linking microbial metabolism to gastric cancer and enhancing prevention efforts.

From BGI Genomics 6 Jan 2026

Periodontal bacterial load associated with disease severity in multiple sclerosis

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders through chronic inflammation.

30 Dec 2025

Reduced peanut OIT dose offers safer, accessible treatment for children

Children with peanut allergies may not need large doses of peanut oral immunotherapy (OIT) to build protection to peanut, finds a new study led by The Hospital for Sick Children (SickKids) and Montreal Children's Hospital. Researchers found that a small dose can help children with their peanut allergy and reduce the risk of severe reactions from accidental exposures, with less side effects than the current standard treatment.

30 Dec 2025

Study demonstrates significant changes in gut bacteria at the onset of IBD

Patients experience significant changes in gut bacteria at the onset of inflammatory bowel disease (IBD), a new international study has found - offering new hope for earlier diagnosis and future treatments.

23 Dec 2025

How GLP‑1 agonists are shaping the future of obesity treatment with Dr Bryony Henderson

GLP-1 agonists are pivotal in obesity care, promoting weight loss and addressing related health issues, with a focus on personalized, holistic treatment.

23 Dec 2025

Prebiotic microcapsules deliver pterostilbene to the colon to alleviate ulcerative colitis

A team led by clinicians and engineers has wrapped the plant-derived polyphenol pterostilbene (PSB) into prebiotic alginate/resistant-starch microcapsules coated with chitosan and shown that oral administration dampens dextran-sulfate-sodium (DSS) colitis in mice.

23 Dec 2025

THC products provide small improvements in pain but carry side effects

A new systematic evidence review finds that cannabis products that carry relatively high levels of the psychoactive compound tetrahydrocannabinol, commonly known as THC, may provide short-term improvements in pain and function.

22 Dec 2025

Oral health gains global recognition in WHO NCD declaration

The European Federation of Periodontology (EFP) welcomes the adoption of the WHO political declaration on noncommunicable diseases (NCDs) and mental health at the Eightieth United Nations General Assembly, recognizing it as a major step forward for integrated, people-centred health systems.

19 Dec 2025

Experimental drug targets early toxic amyloid to slow Alzheimer’s disease

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for Alzheimer's disease.

18 Dec 2025

Injuries don’t rise during menstruation in elite women footballers

The study finds no rise in injuries during menstruation in elite football, yet highlights increased severity, urging better tracking for athlete health.

18 Dec 2025

Oral News and Research

IV iron dextran more cost-effective than oral iron for women with heavy menstrual bleeding and IDA

Arginine can modify plaque formation on teeth and protect against dental caries

Sugarcane protein mouthwash helps protect oral health during head and neck cancer treatment

Breast milk bacteria help shape infant gut microbiome development

Single-dose oral cholera vaccine shows promising results in early clinical trial

BATF2: A novel tumor suppressor silenced by glutamine in head and neck cancer

Cornell-developed nanoparticles improve cancer immunotherapy effectiveness

Enveda’s third asset to the clinic with US FDA IND clearance: What it means for Inflammatory Bowel Disease

New breakthrough could modernize treatment for glioblastoma

Streptococcus anginosus metabolites fuel gastric cancer

New evidence reveals Streptococcus anginosus promotes gastric cancer development

Periodontal bacterial load associated with disease severity in multiple sclerosis

Reduced peanut OIT dose offers safer, accessible treatment for children

Study demonstrates significant changes in gut bacteria at the onset of IBD

How GLP‑1 agonists are shaping the future of obesity treatment with Dr Bryony Henderson

Prebiotic microcapsules deliver pterostilbene to the colon to alleviate ulcerative colitis

THC products provide small improvements in pain but carry side effects

Oral health gains global recognition in WHO NCD declaration

Experimental drug targets early toxic amyloid to slow Alzheimer’s disease

Injuries don’t rise during menstruation in elite women footballers

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News